Cargando…
LUBAC determines chemotherapy resistance in squamous cell lung cancer
Lung squamous cell carcinoma (LSCC) and adenocarcinoma (LADC) are the most common lung cancer subtypes. Molecular targeted treatments have improved LADC patient survival but are largely ineffective in LSCC. The tumor suppressor FBW7 is commonly mutated or down-regulated in human LSCC, and oncogenic...
Autores principales: | Ruiz, E. Josue, Diefenbacher, Markus E., Nelson, Jessica K., Sancho, Rocio, Pucci, Fabio, Chakraborty, Atanu, Moreno, Paula, Annibaldi, Alessandro, Liccardi, Gianmaria, Encheva, Vesela, Mitter, Richard, Rosenfeldt, Mathias, Snijders, Ambrosius P., Meier, Pascal, Calzado, Marco A., Behrens, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6363428/ https://www.ncbi.nlm.nih.gov/pubmed/30642944 http://dx.doi.org/10.1084/jem.20180742 |
Ejemplares similares
-
Ripk1 and haematopoiesis: a case for LUBAC and Ripk3
por: Annibaldi, Alessandro, et al.
Publicado: (2018) -
MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations
por: Liccardi, Gianmaria, et al.
Publicado: (2022) -
Murine Gbp1 and Gbp2 are ubiquitinated independent of Toxoplasma gondii infection
por: Encheva, Vesela, et al.
Publicado: (2018) -
Analysis of Signaling Endosome Composition and Dynamics Using SILAC in Embryonic Stem Cell-Derived Neurons
por: Debaisieux, Solène, et al.
Publicado: (2016) -
Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12
por: Khan, Omar M., et al.
Publicado: (2021)